Unknown

Dataset Information

0

Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.


ABSTRACT:

SUBMITTER: Palubeckaite I 

PROVIDER: S-EPMC9928768 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.

Palubeckaitė Ieva I   Venneker Sanne S   van den Akker Brendy E W M BEWM   Briaire-de Bruijn Inge H IH   Boveé Judith V M G JVMG  

Clinical orthopaedics and related research 20221213 3


<h4>Background</h4>Chondrosarcomas are well known for their resistance to conventional chemotherapy and radiotherapy treatment regimens, which is particularly detrimental in patients who have unresectable tumors. Recently, inhibition of poly(ADP-ribose) polymerase (PARP) by talazoparib was shown to sensitize chondrosarcoma cell lines to chemotherapy (temozolomide) or radiotherapy, irrespective of isocitrate dehydrogenase (IDH) mutation status. Because two-dimensionally grown cell lines have limi  ...[more]

Similar Datasets

| S-EPMC8045153 | biostudies-literature
| S-EPMC4506363 | biostudies-literature
| S-EPMC3315752 | biostudies-literature
| S-EPMC10046822 | biostudies-literature
| S-EPMC4942491 | biostudies-literature
| S-EPMC6171656 | biostudies-literature
| S-EPMC3646083 | biostudies-literature
| S-EPMC7781370 | biostudies-literature
| S-EPMC5650445 | biostudies-literature
| S-EPMC6846262 | biostudies-literature